申请人:Array BioPharma, Inc.
公开号:US20140234376A1
公开(公告)日:2014-08-21
Provided are compositions and methods useful for modulation of signaling through the Toll-like receptors TLR7 and/or TLR8. The compositions and methods have use in treating or preventing disease, including cancer, autoimmune disease, infectious disease, inflammatory disorder, graft rejection, and graft-verses-host disease.
提供了用于调节Toll样受体(TLR7和/或TLR8)信号的组合物和方法。这些组合物和方法在治疗或预防疾病方面具有用途,包括癌症、自身免疫性疾病、感染性疾病、炎症性疾病、移植排斥和移植物抗宿主病。